July 11, 2023 Comments Off on New patent for Allergan drug LINZESS Posted in: Patent Added Annual Drug Patent Expirations for LINZESS Linzess is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent for Allergan drug LINZESS appeared first on DrugPa…
July 11, 2023 Comments Off on New patent for Glaxo Grp drug BREO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…